Myocardial area at risk and salvage measured by T2-weighted cardiovascular magnetic resonance: Reproducibility and comparison of two T2-weighted protocols

Journal of Cardiovascular Magnetic Resonance

Volumn 13, Issue 1, 2011, Pages

  Lønborg, Jacob ^a   Vejlstrup, Niels ^a   Mathiasen, Anders B ^a   Thomsen, Carsten ^a   Jensen, Jan S ^b   Engstrøm, Thomas ^a  

^a University of Copenhagen   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

area at risk; Cardiovascular magnetic resonance; reproducibility; ST segment elevation myocardial infarction; T2 weighted imaging

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; GADOBUTROL; CONTRAST MEDIUM; DIAGNOSTIC AGENT; ORGANOMETALLIC COMPOUND;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; FEMALE; HEART INFARCTION SIZE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVER VARIATION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REPRODUCIBILITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; AGED; CHI SQUARE DISTRIBUTION; COMPUTER ASSISTED DIAGNOSIS; DENMARK; HEART INFARCTION; HEART MUSCLE; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTIVE VALUE; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; DENMARK; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; OBSERVER VARIATION; ORGANOMETALLIC COMPOUNDS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84855163197     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-13-50     Document Type: Article

References (35)

1. Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging. Thiele H, Kappl MJ, Conradi S, Niebauer J, Hambrecht R, Schuler G, J Am Coll Cardiol 2006 47 1641 1645 10.1016/j.jacc.2005.11.065 16631003
2. Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction. Ibrahim T, Bulow HP, Hackl T, Hornke M, Nekolla SG, Breuer M, et al. J Am Coll Cardiol 2007 49 208 216 10.1016/j.jacc.2006.08.047 17222732 (Pubitemid 46054392)
3. Acute myocardial infarction: evaluation with first-pass enhancement and delayed enhancement MR imaging compared with 201Tl SPECT imaging. Lund GK, Stork A, Saeed M, Bansmann MP, Gerken JH, Muller V, et al. Radiology 2004 232 49 57 10.1148/radiol.2321031127 15166320 (Pubitemid 38787819)
4. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, et al. Lancet 2003 361 374 379 10.1016/S0140-6736(03) 12389-6 12573373 (Pubitemid 36164969)
5. Development of cell injury in sustained acute ischemia. Jennings RB, Murry CE, Steenbergen C Jr, Reimer KA, Circulation 1990 82 I2 12 2394018
6. Analysis of myocardial oedema by magnetic resonance imaging early after coronary artery occlusion with or without reperfusion. Garcia-Dorado D, Oliveras J, Gili J, Sanz E, Perez-Villa F, Barrabes J, et al. Cardiovasc Res 1993 27 1462 1469 10.1093/cvr/27.8.1462 8297415 (Pubitemid 23265067)
7. Sustained postinfarction myocardial oedema in humans visualised by magnetic resonance imaging. Nilsson JC, Nielsen G, Groenning BA, Fritz-Hansen T, Sondergaard L, Jensen GB, et al. Heart 2001 85 639 642 10.1136/heart.85.6.639 11359743 (Pubitemid 32973458)
8. "Black blood" T2-weighted inversion-recovery MR imaging of the heart. Simonetti OP, Finn JP, White RD, Laub G, Henry DA, Radiology 1996 199 49 57 8633172
9. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Aletras AH, Tilak GS, Natanzon A, Hsu LY, Gonzalez FM, Hoyt RF Jr, et al. Circulation 2006 113 1865 1870 10.1161/CIRCULATIONAHA.105. 576025 16606793 (Pubitemid 43739398)
10. Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: quantitative assessment during follow-up and validation with single-photon emission computed tomography. Carlsson M, Ubachs JF, Hedstrom E, Heiberg E, Jovinge S, Arheden H, JACC Cardiovasc Imaging 2009 2 569 576 10.1016/j.jcmg.2008.11.018 19442942
11. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. bdel-Aty H, Zagrosek A, Schulz-Menger J, Taylor AJ, Messroghli D, Kumar A, et al. Circulation 2004 109 2411 2416 10.1161/01.CIR.0000127428.10985.C6 15123531 (Pubitemid 38679560)
12. The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. Friedrich MG, bdel-Aty H, Taylor A, Schulz-Menger J, Messroghli D, Dietz R, J Am Coll Cardiol 2008 51 1581 1587 10.1016/j.jacc.2008.01.019 18420102 (Pubitemid 351508364)
13. Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance. Larose E, Rodes-Cabau J, Pibarot P, Rinfret S, Proulx G, Nguyen CM, et al. J Am Coll Cardiol 2010 55 2459 2469 10.1016/j.jacc.2010.02.033 20510213
14. Acute oedema in the evaluation of microvascular reperfusion and myocardial salvage in reperfused myocardial infarction with cardiac magnetic resonance imaging. Phrommintikul A, bdel-Aty H, Schulz-Menger J, Friedrich MG, Taylor AJ, Eur J Radiol 2009
15. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. Ganame J, Messalli G, Dymarkowski S, Rademakers FE, Desmet W, Van de WF, et al. Eur Heart J 2009 30 1440 1449 10.1093/eurheartj/ehp093 19346229
16. T2-prepared SSFP improves diagnostic confidence in edema imaging in acute myocardial infarction compared to turbo spin echo. Kellman P, Aletras AH, Mancini C, McVeigh ER, Arai AE, Magn Reson Med 2007 57 891 897 10.1002/mrm.21215 17457880 (Pubitemid 46709409)
17. Myocardial salvage by CMR correlates with LV remodeling and early ST-segment resolution in acute myocardial infarction. Masci PG, Ganame J, Strata E, Desmet W, Aquaro GD, Dymarkowski S, et al. JACC Cardiovasc Imaging 2010 3 45 51 10.1016/j.jcmg.2009.06.016 20129530
18. Reperfusion haemorrhage as determined by cardiovascular MRI is a predictor of adverse left ventricular remodelling and markers of late arrhythmic risk. Mather AN, Fairbairn TA, Ball SG, Greenwood JP, Plein S, Heart 2010
19. Cardiac MRI of myocardial salvage at the peri-infarct border zones after primary coronary intervention. O'Regan DP, Ahmed R, Neuwirth C, Tan Y, Durighel G, Hajnal JV, et al. Am J Physiol Heart Circ Physiol 2009 297 340 H346 10.1152/ajpheart.00011.2009 19429834
20. Dynamic Changes in ST Segment Resolution After Myocardial Infarction and the Association with Microvascular Injury on Cardiac Magnetic Resonance Imaging. Weaver JC, Ramsay DD, Rees D, Binnekamp MF, Prasan AM, McCrohon JA, Heart Lung Circ 2011 20 111 118 10.1016/j.hlc.2010.09.006 20943440
21. Quantification of myocardial area at risk with T2-weighted CMR: comparison with contrast-enhanced CMR and coronary angiography. Wright J, Adriaenssens T, Dymarkowski S, Desmet W, Bogaert J, JACC Cardiovasc Imaging 2009 2 825 831 10.1016/j.jcmg.2009.02.011 19608131
22. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. N Engl J Med 2000 343 1445 1453 10.1056/NEJM200011163432003 11078769
23. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Mahrholdt H, Wagner A, Holly TA, Elliott MD, Bonow RO, Kim RJ, et al. Circulation 2002 106 2322 2327 10.1161/01.CIR.0000036368. 63317.1C 12403661 (Pubitemid 35244732)
24. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury 167. Rehwald WG, Fieno DS, Chen EL, Kim RJ, Judd RM, Circulation 2002 105 224 229 10.1161/hc0202.102016 11790705 (Pubitemid 34084323)
25. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ, Lancet 2001 357 21 28 10.1016/S0140-6736(00)03567-4 11197356 (Pubitemid 32056497)
26. Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: animal, phantom, and human study. Heiberg E, Ugander M, Engblom H, Gotberg M, Olivecrona GK, Erlinge D, et al. Radiology 2008 246 581 588 18055873
27. Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl- isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Gibbons RJ, Verani MS, Behrenbeck T, Pellikka PA, O'Connor MK, Mahmarian JJ, et al. Circulation 1989 80 1277 1286 10.1161/01.CIR.80.5.1277 2530004 (Pubitemid 19282516)
28. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. Schomig A, Kastrati A, Dirschinger J, Mehilli J, Schricke U, Pache J, et al. N Engl J Med 2000 343 385 391 10.1056/ NEJM200008103430602 10933737 (Pubitemid 30626120)
29. Semi-automatic quantification of myocardial infarction from delayed contrast enhanced magnetic resonance imaging. Heiberg E, Engblom H, Engvall J, Hedstrom E, Ugander M, Arheden H, Scand Cardiovasc J 2005 39 267 275 10.1080/14017430500340543 16269396 (Pubitemid 43203068)
30. Direct T2 quantification of myocardial edema in acute ischemic injury. Verhaert D, Thavendiranathan P, Giri S, Mihai G, Rajagopalan S, Simonetti OP, et al. JACC Cardiovasc Imaging 2011 4 269 278 10.1016/j.jcmg.2010.09.023 21414575
31. T2-prepared SSFP improves diagnostic confidence in edema imaging in acute myocardial infarction compared to turbo spin echo. Kellman P, Aletras AH, Mancini C, McVeigh ER, Arai AE, Magn Reson Med 2007 57 891 897 10.1002/mrm.21215 17457880 (Pubitemid 46709409)
32. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. bdel-Aty H, Zagrosek A, Schulz-Menger J, Taylor AJ, Messroghli D, Kumar A, et al. Circulation 2004 109 2411 2416 10.1161/01.CIR.0000127428.10985.C6 15123531 (Pubitemid 38679560)
33. Prognostic Significance and Determinants of Myocardial Salvage Assessed by Cardiovascular Magnetic Resonance in Acute Reperfused Myocardial Infarction. Eitel I, Desch S, Fuernau G, Hildebrand L, Gutberlet M, Schuler G, et al. J Am Coll Cardiol 2010 55 2470 2479 10.1016/j.jacc.2010.01.049 20510214
34. Cardiac magnetic resonance with edema imaging identifies myocardium at risk and predicts worse outcome in patients with non-ST-segment elevation acute coronary syndrome. Raman SV, Simonetti OP, Winner MW, Dickerson JA, He X, Mazzaferri EL Jr, et al. J Am Coll Cardiol 2010 55 2480 2488 10.1016/j.jacc.2010.01.047 20510215
35. Improving myocardial salvage in late presentation acute ST-elevation myocardial infarction with proximal embolic protection. Larose E, Tizon-Marcos H, Rodes-Cabau J, Rinfret S, Dery JP, Nguyen CM, et al. Catheter Cardiovasc Interv 2010 76 461 470 10.1002/ccd.22588 20506154